PFIZER AT THE VIRTUAL SCIENTIFIC PROGRAM OF THE 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

Pfizer will present data across its industry-leading oncology portfolio, covering multiple tumor types and mechanisms of action. This year, we highlight scientific advancements for people living with cancer with presentations spanning 18 approved and investigational medicines being studied in over 17 cancer types.

Please visit the links below for information on Pfizer Oncology being showcased at the ASCO20 Virtual Scientific Program.

PFIZER ABSTRACT PLAIN LANGUAGE SUMMARIES (APLS) AT THE VIRTUAL SCIENTIFIC PROGRAM OF THE 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

体育投注正规网址To help interested non-scientists better understand the latest research, we are developing summaries in plain language for Pfizer research results presented at medical conferences. We call these “abstract plain language summaries” (APLS).

Visit zawajfun.com/APLS to learn more